name: Heart transplant mRNA gene expression profiling by real time quantitative polymerase chain reaction (PCR) of 20 genes utilizing subfraction of peripheral blood, algorithm reported as a rejection risk score


name: Measurement of alanine aminotransferase, A2-macroglobulin, apolipoprotein A-1, total bilirubin, gamma-glutamyl transferase (GGT), and haptoglobin in serum for assessment of chronic hepatitis C virus infection, prognostic algorithm reported as scores for fibrosis, and necroinflammatory activity in liver


name: Quantitative measurement of acetoacetic acid in serum


name: Quantitative measurement of beta-hydroxybutyrate in serum


name: Quantitative measurement of ketone body in serum


name: Qualitative analysis of acylcarnitine, each specimen


name: Quantitative measurement of acylcarnitine


name: Quantitative measurement of albumin in amniotic fluid, each specimen


name: Quantitative measurement of albumin in cerebrospinal fluid, each specimen


name: Quantitative measurement of albumin in other source, each specimen


name: Semiquantitative analysis of albumin in urine using reagent strip assay


name: Semiquantitative analysis of microalbumin in urine using reagent strip assay


name: Semiquantitative measurement of albumin in urine


name: Semiquantitative measurement of mircroalbumin in urine


name: Measurement of alcohol level in breath specimen


name: Measurement of ethanol in breath specimen


name: Alcohol (ethanol); any specimen except urine and breath, immunoassay (eg, IA, EIA, ELISA, RIA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)


name: Measurement of alcohol level in specimen other than breath or urine


name: Measurement of ethanol by alcohol dehydrogenase assay for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzymatic assay for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzyme immunoassay (EIA) for ethanol in specimen other than breath or urine


name: Measurement of ethanol by enzyme-linked immunosorbent assay (ELISA) for ethanol in specimen other than breath or urine , immunoassay (eg, IA, EIA, ELISA, RIA, EMIT, FPIA) and enzymatic methods (eg, alcohol dehydrogenase)


name: Measurement of ethanol by fluorescence polarization immunoassay (FPIA) for ethanol in specimen other than breath or urine


name: Measurement of ethanol by radio immunoassay (RIA) for ethanol in specimen other than breath or urine


name: Alpha-1-antitrypsin (protein) blood test, total


name: Qualitative analysis of single amino acid


name: Amino acid analysis, multiple amino acids, qualitative, each specimen


name: Amino acid analysis, quantitative, each specimen


name: Quantitative testing of single amino acid


name: Amino acid level, 2 to 5 amino acids, quantitative, each specimen


name: Measurement of 2-5 amino acids, each specimen


name: Measurement of 6 or more amino acids, each specimen


name: Measurement of apolipoprotein, each apolipoprotein tested


name: Measurement of biotinidase, each specimen


name: Qualitative analysis of occult blood in consecutively collected fecal specimens by peroxidase activity, single determination, for colorectal neoplasm screening


name: Qualitative analysis of nonfecal occult blood by peroxidase activity


name: Stool analysis for blood, by peroxidase activity


name: Qualitative analysis of occult blood in feces by peroxidase activity, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening


name: Qualitative fecal hemoglobin, 1-3 simultaneous determinations by immunoassay for blood in feces


name: Calcium level, after calcium infusion test


name: Measurement of carbon dioxide (bicarbonate)


name: Measurement of carcinoembryonic antigen (CEA)


name: Quantitative measurement of free and total carnitine


name: Measurement of cholinesterase in red blood cells (RBCs)


name: Quantitative measurement of chondroitin B sulfate


name: Qualitative column chromatography for nondrug analyte, each specimen


name: Qualitative column chromatography with mass spectroscopy for nondrug analyte, each specimen


name: Quantitative column chromatography for nondrug analyte, each specimen


name: Quantitative column chromatography with mass spectroscopy for nondrug analyte, each specimen


name: Creatine kinase (cardiac enzyme) level, total


name: Measurement of total creatine kinase (CK/CPK)


name: Creatine kinase (cardiac enzyme) level, isoenzymes


name: Creatine kinase (cardiac enzyme) level, MB fraction only


name: Measurement of creatine kinase (CK/CPK) muscle and brain (MB) fraction


name: Measurement of creatine kinase (CK/CPK) isoforms


name: Measurement of creatinine (source other than blood)


name: Semiquantitative analysis of cryoglobulin


name: Cyanocobalamin (vitamin B-12) level, unsaturated binding capacity


name: Measurement of dihydrotestosterone (DHT)


name: Semiquantitative analysis of pancreatic elastase (EL-1) in feces


name: Enzyme activity measurement, nonradioactive substrate


name: Assay of enzyme activity in blood cells (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in cultured cells (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in tissue (not elsewhere specified) with nonradioactive substrate, each specimen


name: Assay of enzyme activity in blood cells (not elsewhere specified) with radioactive substrate, each specimen


name: Assay of enzyme activity in cultured cells (not elsewhere specified) with radioactive substrate, each specimen


name: Assay of enzyme activity in tissue (not elsewhere specified) with radioactive substrate, each specimen


name: Electrophoretic technique (not elsewhere specified)


name: Measurement of total estradiol (hormone)


name: Estradiol; free, direct measurement (eg, equilibrium dialysis)


name: Stool fat or lipids analysis, qualitative


name: Quantitative measurement of fat in feces


name: Quantitative measurement of lipids in feces


name: Stool fat differential measurement, quantitative


name: Quantitative measurement of fat differential in feces


name: Measurement of folic acid in red blood cells (RBCs)


name: Measurement of galactokinase in red blood cells (RBCs)


name: Gammaglobulin (immune system protein) measurement, immunoglobulin subclasses


name: Analysis of bicarbonate (HCO3) of blood in combination with other blood gas


name: Analysis of carbon dioxide (CO2) of blood in combination with other blood gas


name: Analysis of pH of blood in combination with other blood gas


name: Analysis of partial pressure of carbon dioxide (pCO2) of blood in combination with other blood gas


name: Analysis of partial pressure of oxygen (pO2) of blood in combination with other blood gas


name: Calculated oxygen (O2) saturation of blood


name: Blood gases measurement, with O2 saturation


name: Analysis of HCO3 of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of carbon dioxide (CO2) of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pCO2 of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pH of blood in combination with other blood gas with oxygen (O2) saturation


name: Analysis of pO2 of blood in combination with other blood gas with oxygen (O2) saturation


name: Direct measurement of only oxygen (O2) saturation in blood (except pulse oximetry)


name: Gastric acid analysis with pH, each specimen


name: Gastrin (GI tract hormone) level, after secretin stimulation


name: Measurement of glucose in blood (except reagent strip)


name: Blood glucose (sugar) tolerance test, 3 specimens


name: Glucose tolerance test (GTT), 3 specimens


name: Blood glucose (sugar) tolerance test, each additional beyond 3 specimens


name: Glucose tolerance test (GTT), each additional specimen beyond 3


name: Quantitative measurement of glucose-6-phosphate dehydrogenase (G6PD)


name: Measurement of glutathione reductase in red blood cells (RBCs)


name: Analysis of Helicobacter pylori urease activity in blood using C13 isotope


name: Analysis of urease activity in breath using C13 isotope for presence of Helicobacter pylori


name: Qualitative screening for heavy metal, any number of analytes


name: Quantitative measurement of heavy metal (not elsewhere specified), each metal measured


name: Hemoglobin analysis and measurement, electrophoresis


name: Fractionation and quantitation of hemoglobin using electrophoresis


name: Fractionation and measurement of hemoglobin using chromatography


name: Nonautomated measurement of hemoglobin using copper sulfate method


name: Qualitative analysis of fetal hemoglobin (Hb F)


name: Hemoglobin A1C level, by device for home use


name: Quantitative measurement of methemoglobin in hemoglobin


name: Quantitative measurement of sulfhemoglobin in hemoglobin


name: Measurement of b-hexosaminidase, each assay


name: Hydroxyproline (amino acid) measurement, free


name: Analysis of substance using immunoassay technique, multiple step method


name: Measurement of substance using immunoassay technique, by radioimmunoassay


name: Ketosteroids, 17 (hormone) measurement, total


name: Ketosteroids, 17 (hormone) measurement, fractionation


name: Measurement of human placental lactogen (HPL)


name: Lipoprotein level, electrophoretic separation and quantitation


name: Separation and quantitation of lipoprotein in blood using electrophoresis


name: High resolution fractionation and quantitation of lipoprotein with subclasses in blood


name: Lipoprotein level, quantitation of lipoprotein particle number(s)


name: Quantitation of lipoprotein particle numbers in blood


name: Quantitation of lipoprotein particle numbers with lipoprotein subclasses in blood


name: Qualitative mass spectrometry and tandem mass spectrometry, non-drug analyte (not elsewhere specified), each specimen


name: Quantitative mass spectrometry and tandem mass spectrometry, non-drug analyte (not elsewhere specified), each specimen


name: Analysis of myelin basic protein (MBP) in cerebrospinal fluid


name: Nephelometry, each analyte (not elsewhere specified)


name: Quantitative measurement of total organic acids, each specimen


name: Qualitative analysis of organic acids, each specimen


name: Quantitative measurement of single organic acid


name: Phosphatase (enzyme) level, alkaline, heat stable


name: Measurement of heat stable alkaline phosphatase (total not included)


name: Phosphatase (enzyme) measurement, alkaline, isoenzymes


name: Measurement of 6-phosphogluconate dehydrogenase in red blood cells (RBCs)


name: Qualitative evaluation of cervicovaginal fluid for placental alpha microglobulin-1 (PAMG-1), each specimen


name: Qualitative evaluation of cervicovaginal fluid for specific amniotic fluid protein, each specimen


name: Measurement of prostaglandin, each prostaglandin measured


name: PSA (prostate specific antigen) measurement, complexed


name: Measurement of total protein in plasma (except by refractometry)


name: Measurement of total protein in serum (except by refractometry)


name: Measurement of total protein in whole blood (except by refractometry)


name: Measurement of total protein in urine (except by refractometry)


name: Measurement of total protein (except by refractometry)


name: Measurement of total protein using refractometry, any source


name: Fractionation and quantitation of protein in serum using electrophoresis


name: Fractionation and quantitation of protein in concentrated body fluid (other than serum) using electrophoresis


name: Western blot protein immunoassay on blood with interpretation and report


name: Western blot protein immunoassay on body fluid (other than blood) with interpretation and report


name: Protein measurement, immunological probe for band identification


name: Western blot protein immunological probe for band identification in blood with interpretation and report, each


name: Western blot protein immunological probe for band identification in body fluid (other than blood) with interpretation and report, each


name: Quantitative measurement protoporphyrin in red blood cells (RBCs)


name: Screening for protoporphyrin in red blood cells (RBCs)


name: Assay for endocrine receptor (other than estrogen or progesterone)


name: Spectrophotometry (analyte not elsewhere specified)


name: Measurement of specific gravity (except urine)


name: Analysis of sugars using thin-layer chromatography (TLC)


name: Carbohydrate analysis, single qualitative


name: Single qualitative analysis of sugars, each specimen


name: Carbohydrate analysis, multiple qualitative


name: Multiple qualitative analysis of sugars, each specimen


name: Carbohydrate analysis, single quantitative


name: Single quantitative analysis of sugars, each specimen


name: Carbohydrate analysis, multiple quantitative


name: Multiple quantitative analysis of sugars, each specimen


name: Direct measurement of bioavailable testosterone


name: Thyroxine (thyroid chemical), requiring elution


name: Measurement of triiodothyronine (T3) uptake


name: Thyroid hormone, T3 measurement, reverse


name: Troponin (protein) analysis, qualitative


name: Urea nitrogen level to assess kidney function, quantitative


name: Quantitative measurement of blood urea nitrogen (BUN)


name: Urea nitrogen level to assess kidney function, urine


name: Urea nitrogen level to assess kidney function, clearance


name: Measurement of uric acid (other than blood)


name: Quantitative measurement of urobilinogen in feces


name: Measurement of vitamin (not otherwise specified)


name: Estimated leukocyte and platelet count by microscopic examination of blood smear with manual differential leukocyte (WBC) count


name: Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count


name: Automated complete blood cell count (CBC)


name: Manual blood cell count, each blood cell type


name: Manual platelet count, each blood cell type


name: Manual red blood cell (RBC) count, each blood cell type


name: Manual white blood cell (WBC) count, each blood cell type


name: Automated reticulocyte count with multiple cellular parameters, direct measurement


name: Automated reticulocyte count with single cellular parameter, direct measurement


name: Assay for clotting factor II (prothrombin)


name: Assay for clotting factor V (accelerated globulin [AcG])


name: Assay for clotting factor V (proaccelerin)


name: 1-stage assay for clotting factor VIII (antihemophilic globulin [AHG])


name: Assay for coagulation factor VIII (von Willebrand [VW]) using ristocetin cofactor


name: Assay for factor VIII antigen (von Willebrand [VW])


name: Assay for clotting factor VIII (von Willebrand [VW]) with multimetric analysis


name: Assay for clotting factor IX (Christmas factor)


name: Assay for clotting factor IX (plasma thromboplastin component [PTC])


name: Assay for high molecular weight kininogen (Fitzgerald factor assay)


name: Coagulation time measurement, Lee and White


name: Coagulation time measurement, other methods


name: Coagulation time test (other methods not specified elsewhere)


name: Semiquantitative analysis of fibrin degradation products (FDP) and fibrinogen split products (FSP) using agglutination slide method


name: Coagulation function measurement, paracoagulation


name: Analysis of fibrin degradation products (FDP) and fibrinogen split products (FSP) using paracoagulation method


name: Coagulation function measurement, quantitative


name: Measurement of fibrin degradation products (FDP) and fibrinogen split products (FSP)


name: Coagulation function measurement, qualitative or semiquantitative


name: Semiquantitative analysis of D-dimer fibrin degradation products


name: Coagulation function measurement, D-dimer; quantitative


name: Coagulation function measurement, ultrasensitive, qualitative or semiquantitative


name: Ultrasensitive semiquantitative analysis of D-dimer fibrin degradation products


name: Screening for coagulopathy with interpretation and written report


name: Screening for fibrinolysins with interpretation and written report


name: Coagulation/fibrinolysis assay on whole blood using pharmacologic additive, with interpretation and written report, per day


name: Analysis of functional activity of coagulation and fibrinolysis (not otherwise specified), each analyte


name: Measurement of plasminogen (excluding antigenic assay)


name: Evaluation of red blood cell defect (Heinz bodies), direct


name: Induced Heinz bodies stain using acetylphenylhydrazine


name: Fetal hemoglobin or red blood cells measurement for assessment of fetal-maternal circulation, differential lysis


name: Rosette test for fetal red blood cells (RBCs) for fetomaternal hemorrhage


name: Red blood cell (RBC) mechanical fragility test


name: Red blood cell fragility measurement, unincubated


name: Unincubated red blood cell (RBC) osmotic fragility test


name: Red blood cell fragility measurement, incubated


name: Incubated red blood cell (RBC) osmotic fragility test


name: In vitro platelet aggregation study, each agent


name: Prothrombin time test with substitution of plasma fractions, each test


name: Clotting factor X assessment test, undiluted


name: Red blood cell sedimentation rate, to detect inflammation, automated


name: Sickling of red blood cell (RBC) using reduction test


name: Thrombin time, fibrinogen screening test, plasma


name: Coagulation assessment blood test, plasma or whole blood


name: Partial thromboplastin time test (PTT) using plasma


name: Partial thromboplastin time test (PTT) using whole blood


name: Partial thromboplastin time test (PTT) with substitution of plasma fractions, each test


name: Measurement of antibody (IgG) to allergic substance, each allergen


name: Quantitative allergen-specific immunoglobulin G (IgG) test, each allergen


name: Semiquantitative allergen-specific immunoglobulin G (IgG) test, each allergen


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using crude allergen extract, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using crude allergen extract, each allergen


name: Measurement of antibody (IgE) to allergic substance, multiallergen screen


name: Qualitative multiallergen screening for allergen-specific immunoglobulin E (IgE)


name: Measurement of antibody (IgE) to allergic substance, recombinant or purified component, each


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using purified allergen component, each allergen


name: Quantitative measurement of allergen-specific immunoglobulin E (IgE) using recombinant allergen component, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using purified allergen component, each allergen


name: Semiquantitative measurement of allergen-specific immunoglobulin E (IgE) using recombinant allergen component, each allergen


name: Antibody identification test, platelet associated immunoglobulin assay


name: Measurement of antibody for assessment of autoimmune disorder, titer


name: Evaluation of blood cross match and evaluation of irregular antibody with interpretation and written report


name: Investigation of transfusion reaction, including suspicion of transmissible disease, with interpretation and written report


name: Measurement C-reactive protein for detection of infection or inflammation, high sensitivity


name: Measurement of high sensitivity C-reactive protein (hsCRP)


name: Assay for beta 2 Glycoprotein I antibody, each antibody


name: Assay for cardiolipin (phospholipid) antibody, each Ig class


name: Measurement of complement (immune system proteins), antigen,


name: Assay for complement antigen, each component


name: Assay for functional activity of complement antigen, each component


name: Measurement of complement fixation tests (immune system proteins)


name: Complement antigen fixation test, each antigen


name: Measurement of DNA antibody, native or double stranded


name: Assay for double stranded deoxyribonuclease acid (DNA) antibody


name: Assay for native deoxyribonuclease acid (DNA) antibody


name: Assay for single stranded deoxyribonuclease acid (DNA) antibody


name: Screening using fluorescent noninfectious agent antibody, each antibody


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 15-3


name: Quantitative immunoassay for CA 15-3 (27.29) tumor antigen


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 19-9


name: Immunologic analysis for detection of tumor antigen, quantitative; CA 125


name: Quantitative immunoassay for tumor antigen, each


name: Detection of infectious agent antibody, quantitative


name: Quantitative immunoassay for infectious agent antibody (not otherwise specified)


name: Semiquantitative immunoassay for infectious agent antibody using reagent strip


name: Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])


name: Test for detection of severe acute respiratory syndrome coronavirus 2 (Covid-19) antibody, qualitative or semiquantitative


name: Qualitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using single-step method


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using reagent strip


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody using single-step method


name: Immunoelectrophoresis of body fluid (other than serum) with concentration


name: Immunologic analysis technique, unspecified


name: Immunodiffusion (not elsewhere specified)


name: Qualitative gel diffusion, each antibody


name: Immunologic analysis technique on serum (immunofixation)


name: Immunologic analysis technique on body fluid, other fluids with concentration


name: Immunofixation electrophoresis of body fluid (other than serum) with concentration


name: White blood cell function measurement, mitogen or antigen induced blastogenesis


name: Lymphocyte transformation using antigen induced blastogenesis


name: Lymphocyte transformation using mitogen induced blastogenesis


name: Quantitative measurement of mononuclear cell antigen (not otherwise specified), each antigen


name: Analysis of microsomal antibody, each antibody


name: Screening for particle agglutination, each antibody


name: Particle agglutination titer, each antibody


name: Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); screen


name: Screening test for detection of severe acute respiratory syndrome coronavirus 2 (Covid-19) neutralizing antibody


name: Screen for neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)


name: Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); titer


name: Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (COVID-19)


name: Quantitative measurement of rheumatoid factor


name: Tuberculosis test, enumeration of T-cells


name: Unlisted antigen skin test, each antigen


name: Qualitative assay for syphilis-related nontreponemal antibody


name: Quantitative assay for syphilis-related nontreponemal antibody


name: Bacterium (not specified elsewhere) antibody assay


name: Chlamydia immunoglobulin M (IgM) antibody titer


name: Cytomegalovirus (CMV) immunoglobulin M (IgM) antibody titer


name: Analysis for antibody to Epstein-Barr virus (mononucleosis virus), early antigen


name: Analysis for antibody to Epstein-Barr virus (mononucleosis virus), nuclear antigen


name: Assay for fungus antibody (not elsewhere specified)


name: Assay for helminth antibody (not elsewhere specified)


name: Human T cell lymphotropic virus Type I (HTLV-I) antibody titer


name: Human T cell lymphotropic virus Type II virus (HTLV-II) antibody titer


name: Confirmatory test for Human T cell lymphotropic I virus (HTLV-I) antibody


name: Confirmatory test for Human T cell lymphotropic II virus (HTLV-II) antibody


name: Confirmatory test for human immunodeficiency virus (HIV) antibody


name: Assay for hepatitis delta (HepD) agent antibody


name: Nonspecific herpes simplex virus (HSV) antibody titer


name: Herpes simplex type 1 (HSV 1) antibody titer


name: Herpes simplex type 2 (HSV 2) antibody titer


name: Assay for human immunodeficiency virus type 1 (HIV-1) antibody


name: Assay for human immunodeficiency virus type 2 (HIV-2) antibody


name: Combined assay for human immunodeficiency virus type 1 and 2 (HIV-1, HIV-2) antibodies


name: Assay for hepatitis B core antibody (HBcAb) immunoglobulin M (IgM) core antibody


name: Assay for Hepatitis A antibody (HAAb) immunoglobulin M (IgM) antibody


name: Assay for John Cunningham (JC) virus antibody


name: John Cunningham (JC) virus antibody titer


name: Assay for protozoa antibody (not elsewhere specified)


name: Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])


name: Measure of severe acute respiratory syndrome coronavirus 2 (Covid-19) antibody


name: Measurement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody


name: Tetanus (Clostridium tetani) antibody titer


name: Toxoplasma immunoglobulin M (IgM) antibody titer


name: Assay for West Nile virus immunoglobulin M (IgM) antibody


name: Assay for virus antibody (not elsewhere specified)


name: Assay for Zika virus immunoglobulin M (IgM) antibody


name: Confirmatory hepatitis C (HepC) antibody titer


name: Immunologic analysis for autoimmune disease, with titration


name: Immunologic analysis for autoimmune disease, without titration


name: Transplant antibody measurement, quick method


name: Screening for cytotoxic percent reactive antibody (PRA) in serum using quick method


name: Immunologic analysis for autoimmune disease, A, B, or C, single antigen


name: Human leukocyte antigen (HLA) typing of antigen A, single antigen


name: Human leukocyte antigen (HLA) typing of antigen B, single antigen


name: Human leukocyte antigen (HLA) typing of antigen C, single antigen


name: Immunologic analysis for autoimmune disease, A, B, or C, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen A, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen B, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen C, multiple antigens


name: Immunologic analysis for autoimmune disease, DR/DQ, single antigen


name: Human leukocyte antigen (HLA) typing of antigen DQ, single antigen


name: Human leukocyte antigen (HLA) typing of antigen DR, single antigen


name: Immunologic analysis for autoimmune disease, DR/DQ, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen DQ, multiple antigens


name: Human leukocyte antigen (HLA) typing of antigen DR, multiple antigens


name: Immunologic analysis for autoimmune disease, lymphocyte culture, mixed


name: Mixed lymphocyte culture (MLC) for human leukocyte antigen (HLA) typing


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, first sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, first serum sample


name: Immunologic analysis for organ transplant, each additional serum sample or sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, each additional sample dilution


name: Human leukocyte antigen (HLA) crossmatch using noncytotoxic method, each additional serum sample


name: Qualitative assessment for antibody detection of human leukocyte antigens (HLA) Class I and II


name: Qualitative assessment for antibody detection of human leukocyte antigen (HLA) Class I


name: Qualitative assessment for antibody detection of human leukocyte antigen (HLA) Class II


name: Antibody detection for human leukocyte antigen (HLA) class I by qualitative panel using complete HLA phenotypes


name: Antibody detection for human leukocyte antigen (HLA) class II by qualitative panel using complete HLA phenotypes


name: Antibody detection with high definition qualitative panel for human leukocyte antigen (HLA) class I


name: Antibody detection for human leukocyte antigen (HLA) class I by semiquantitative panel


name: Antibody detection for human leukocyte antigen (HLA) class II by semiquantitative panel


name: Screening for red blood cell (RBC) antibody, each serum technique


name: Elution of red blood cell (RBC) antibody, each elution


name: Red blood cell (RBC) antibody panel, each panel for each serum technique


name: Red blood cell antibody detection test, indirect


name: Indirect qualitative antihuman globulin test (Coombs test), each reagent red cell


name: Indirect antihuman globulin test (Coombs test), each antibody titer


name: Processing and storage of blood unit or component, predeposited


name: Intraoperative salvage, collection processing, and storage of autologous blood


name: Intraoperative salvage, collection processing, and storage of autologous blood component


name: Postoperative salvage, collection processing, and storage of autologous blood


name: Postoperative salvage, collection processing, and storage of autologous blood component


name: Antigen testing of donor blood using reagent serum, each antigen test


name: Screening test for compatible blood unit, using patient serum


name: Antigen screening of donor blood for compatibility using patient serum, per unit screened


name: Red blood cell (RBC) antigen testing (other than ABO or Rh (D), each RBC antigen


name: Compatibility testing of blood for transfusion using immediate spin technique, each unit


name: Blood unit compatibility test, incubation technique


name: Compatibility testing of blood for transfusion using incubation spin technique, each unit


name: Blood unit compatibility test, antiglobulin technique


name: Compatibility testing of blood for transfusion using antiglobulin technique, each unit


name: Blood unit compatibility test, electronic


name: Electronic compatibility testing of blood for transfusion, each unit


name: Thawing of fresh frozen plasma, each unit


name: Preparation and freezing of blood, each unit


name: Preparation, freezing, and thawing of frozen blood, each unit


name: Screening of auto-hemolysins and auto-agglutinins, each screen


name: Volume reduction of blood product, each unit


name: Pretreatment of red blood cells for use in red blood cells antibody analysis and measurement, incubation with chemical agents or drugs


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation, with each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation, each chemical agent


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation, each drug


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification by incubation with enzyme, each enzyme


name: Pretreatment of red blood cells for use in red blood cells antibody analysis and measurement, by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection and identification by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody detection, identification, and compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification and compatibility testing by density gradient separation


name: Pretreatment of red blood cells (RBCs) for use in red blood cell antibody identification by density gradient separation


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, incubation with drugs


name: Pretreatment of serum by incubation with drug for use in red blood cell (RBC) antibody identification, each


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, by dilution


name: Pretreatment of serum by dilution for use in red blood cell (RBC) antibody identification


name: Pretreatment of serum for use in red blood cell antibody analysis and measurement, incubation with inhibitors


name: Pretreatment of serum by incubation with inhibitors for use in red blood cell (RBC) antibody identification, each


name: Pretreatment of serum for use in red blood cell antibody identification by differential red cell absorption using patient red blood cells (RBCs), each absorption


name: Pretreatment of serum for use in red blood cell antibody identification by differential red cell absorption using red blood cells (RBCs) of known phenotype, each absorption


name: Aerobic bacterial culture of stool with isolation and presumptive identification of isolate, each plate


name: Bacterial culture, any other source except urine, blood or stool, aerobic


name: Bacterial culture, any source except aerobic urine, aerobic blood and aerobic stool, with isolation and presumptive identification of isolate


name: Quantitative aerobic bacterial culture with isolation and presumptive identification of isolate, any source except urine, blood, or stool


name: Quantitative anaerobic bacterial culture with isolation and presumptive identification of isolate, any source except urine, blood, or stool


name: Bacterial culture, any source, except blood, anaerobic


name: Bacterial culture with isolation and presumptive identification of isolate, any source except anaerobic blood


name: Definitive identification of anaerobic isolate in bacterial culture using additional methods, each isolate


name: Definitive identification of aerobic isolate in bacterial culture using additional methods, each isolate


name: Presumptive culture for pathogenic organism, screening only


name: Presumptive culture for pathogenic organism, screening only, with colony estimation using density chart


name: Presumptive identification of isolate from fungal culture (except blood)


name: Definitive identification of yeast organism isolated from fungal culture


name: Definitive identification of mold isolated from fungal culture


name: Bacterial culture for Mycoplasma, any source


name: Bacterial culture for Chlamydia, any source


name: Bacterial culture for acid-fast bacilli with isolation and presumptive identification of isolate, any source


name: Procedure for definitive identification of Mycobacterium isolated from bacterial culture, each isolate


name: Identification of organisms by immunologic analysis, immunofluorescent method


name: Typing of culture using immunofluorescent method, each antiserum


name: Typing of culture using gas liquid chromatography (GLC) method


name: Typing of culture using high pressure liquid chromatography (HPLC) method


name: Typing of culture using immunologic method other than immunofluorescence, per antiserum


name: Typing of culture with identification by direct nucleic acid probe technique, per culture, each organism probed


name: Typing of culture with identification by direct nucleic acid probe technique, per isolate, each organism probed


name: Identification of organisms by genetic analysis, amplified probe technique


name: Typing of culture with identification by amplified nucleic acid probe technique, per culture, each organism probed


name: Typing of culture with identification by amplified nucleic acid probe technique, per isolate, each organism probed


name: Identification of organisms by nucleic acid sequencing method


name: Typing of culture with identification using nucleic acid sequencing method, each isolate


name: Typing of culture using method (not elsewhere specified)


name: Dark field microscopic examination for organism, includes specimen collection


name: Specimen collection and dark field examination, any source


name: Concentration and identification of direct smear for ova and parasites


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), agar dilution method


name: Antimicrobial agent susceptibility study using agar dilution method, per agent


name: Antimicrobial agent susceptibility study using disk method, per plate, 12 or fewer agents


name: Detection of antimicrobial drug (antibiotic, antifungal, antiviral)


name: Antimicrobial agent susceptibility study using enzyme detection, per enzyme


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution


name: Minimum inhibitory concentration (MIC) antimicrobial agent susceptibility study using agar dilution method, each antimicrobial, per plate


name: Minimum inhibitory concentration (MIC) antimicrobial agent susceptibility study using microdilution method, each antimicrobial, per plate


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution, each plate


name: Minimum lethal concentration (MLC) antimicrobial agent susceptibility study using agar dilution method, per plate


name: Minimum lethal concentration (MLC) antimicrobial agent susceptibility study using microdilution method, per plate


name: Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), macrobroth dilution method


name: Antimicrobial agent susceptibility study using macrobroth dilution method, each agent


name: Antimicrobial agent susceptibility study on mycobacteria using proportion method, each agent


name: Special Gram or Giemsa stain for microorganism


name: Special fluorescent and/or acid fast stain for microorganism


name: Smear from primary source with fluorescent and acid fast stain for bacteria, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for cell type, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for fungus, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for parasite, with interpretation


name: Smear from primary source with fluorescent and acid fast stain for virus with interpretation


name: Special stain for inclusion bodies or parasites


name: Wet mount smear from primary source for infectious agent, with interpretation


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from hair for mite


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from nail for mite


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for ectoparasite ova


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for fungus


name: Tissue examination by potassium hydroxide (KOH) slide of sample from skin for mite


name: Additional study of tissue culture viral isolate, each isolate


name: Definitive identification of tissue culture viral isolate, each isolate


name: Virus isolation using centrifuge enhanced technique and identification using immunofluorescence stain, each virus


name: Virus isolation and identification by nonimmunologic method


name: Adenovirus antigen detection by immunofluorescent technique


name: Bordetella parapertussis antigen detection by immunofluorescent technique


name: Bordetella pertussis antigen detection by immunofluorescent technique


name: Enterovirus antigen detection by direct fluorescent antibody (DFA) technique


name: Detection test by immunofluorescent technique for giardia (intestinal parasite)


name: Giardia antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for chlamydia


name: Chlamydia trachomatis antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for cytomegalovirus (CMV)


name: Cytomegalovirus antigen detection by direct fluorescent antibody (DFA) technique


name: Cryptosporidium antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for herpes simplex virus type 2


name: Herpes simplex virus type 2 antigen detection by immunofluorescent technique


name: Herpes simplex virus type 1 antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for influenza B virus


name: Influenza B virus antigen detection by immunofluorescent technique


name: Influenza A virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for legionella pneumophila (water borne bacteria)


name: Legionella pneumophila antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for parainfluenza virus


name: Parainfluenza virus antigen detection by immunofluorescent technique, each type


name: Respiratory syncytial virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for pneumocystis carinii (respiratory parasite)


name: Pneumocystis carinii antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for rubeola (measles virus)


name: Rubeola antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for treponema pallidum (syphilis organism)


name: Treponema pallidum antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for varicella (chicken pox) zoster virus


name: Varicella zoster virus antigen detection by immunofluorescent technique


name: Detection test by immunofluorescent technique for organism


name: Polyvalent infectious agent antigen detection using immunofluorescent technique, each organism


name: Detection test by immunofluorescent technique for multiple organisms


name: Detection test by immunoassay technique for adenovirus enteric types 40/41


name: Detection test by immunoassay technique for Aspergillus (fungus)


name: Detection test by immunoassay technique for Clostridium difficile toxins (stool pathogen)


name: Detection test by immunoassay technique for Cryptosporidium (parasite)


name: Detection test by immunoassay technique for cytomegalovirus


name: Detection test by immunoassay technique for Escherichia coli 0157 (E. coli)


name: Detection test by immunoassay technique for Entamoeba histolytica dispar group (parasite)


name: Detection test by immunoassay technique for Entamoeba histolytica group (parasite)


name: Detection test by immunoassay technique for Helicobacter pylori (GI tract bacteria)


name: Detection test by immunoassay technique for hepatitis B surface antigen neutralization


name: Detection test by immunoassay technique for hepatitis Be surface antigen


name: Detection test by immunoassay technique for hepatitis D


name: Detection test by immunoassay technique for Histoplasma capsulatum (parasite)


name: Detection test by immunoassay technique for respiratory syncytial virus (RSV)


name: Detection test by immunoassay technique for rotavirus


name: Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])


name: Qualitative enzyme immunoassay (EIA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Qualitative enzyme-linked immunosorbent assay (ELISA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Qualitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen using multiple-step method


name: Qualitative immunochemiluminometric assay (IMCA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative enzyme immunoassay (EIA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative enzyme-linked immunosorbent assay (ELISA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Semiquantitative immunoassay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen using multiple-step method


name: Semiquantitative immunochemiluminometric assay (IMCA) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen


name: Detection test by immunoassay technique for Streptococcus, group A (strep)


name: Infectious agent antigen detection using qualitative multiple step immunoassay technique (not otherwise specified), each organism


name: Unspecified infectious agent antigen detection using semiquantitative multiple step immunoassay technique (not otherwise specified), each organism


name: Polyvalent infectious agent antigen detection by qualitative multiple step immunoassay technique, each polyvalent antiserum


name: Polyvalent infectious agent antigen detection by semiquantitative multiple step immunoassay technique, each polyvalent antiserum


name: Detection by nucleic acid Bartonella henselae and Bartonella quintana (bacteria), amplified probe technique


name: Bartonella henselae detection by amplified nucleic acid probe technique


name: Bartonella quintana detection by amplified nucleic acid probe technique


name: Detection by nucleic acid Bartonella henselae and Bartonella quintana (bacteria), quantification


name: Bartonella henselae quantification by nucleic acid probe technique


name: Bartonella quintana quantification by nucleic acid probe technique


name: Detection by nucleic acid for borrelia burgdorferi (bacteria), direct probe technique


name: Borrelia burgdorferi detection by direct nucleic acid probe technique


name: Detection by nucleic acid for borrelia burgdorferi (bacteria), amplified probe technique


name: Borrelia burgdorferi detection by amplified nucleic acid probe technique


name: Candida detection by direct nucleic acid probe technique


name: Detection test for candida species (yeast), amplified probe technique


name: Candida detection by amplified nucleic acid probe technique


name: Detection test for candida species (yeast), quantification


name: Candida quantification by nucleic acid probe technique


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique and multiplex reverse transcription, multiple subtypes, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique and multiplex reverse transcription, multiple types, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique, multiple subtypes, 12-25 targets


name: Central nervous system infectious agent pathogen detection using nucleic acid multiplex amplified probe technique, multiple types, 12-25 targets


name: Detection test by nucleic acid for chlamydia pneumoniae, direct probe technique


name: Chlamydia pneumoniae detection by direct nucleic acid probe technique


name: Chlamydia pneumoniae detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia pneumoniae, quantification


name: Chlamydia pneumoniae quantification by nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia, direct probe technique


name: Chlamydia trachomatis detection by direct nucleic acid probe technique


name: Chlamydia trachomatis detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for chlamydia trachomatis, quantification


name: Chlamydia trachomatis quantification by nucleic acid probe technique


name: Detection test by nucleic acid for clostridium difficile, amplified probe technique


name: Clostridium difficile toxin gene detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for cytomegalovirus (CMV), direct probe technique


name: Cytomegalovirus detection by direct nucleic acid probe technique


name: Cytomegalovirus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for cytomegalovirus, quantification


name: Cytomegalovirus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique


name: Enterovirus detection by amplified nucleic acid probe technique


name: Enterovirus detection by amplified nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for Vancomycin resistance strep (VRE), amplified probe technique


name: Vancomycin resistant bacteria detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for influenza virus, each type or subtype


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each subtype


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each type


name: Detection test by nucleic acid for multiple types influenza virus


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, first 2 subtypes


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, first 2 types


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each additional influenza virus type


name: Influenza virus detection by nucleic acid using multiplex reverse transcription and amplified probe technique, each additional sub-type beyond 2


name: Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets


name: Gastrointestinal pathogen detection by nucleic acid using multiplex reverse transcription and multiplex amplified probe technique, 3-5 targets


name: Gastrointestinal pathogen detection by nucleic acid using multiplex reverse transcription and multiplex amplified probe technique, 6-11 targets


name: Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique and multiplex reverse transcription, multiple subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique and multiplex reverse transcription, multiple types, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique, multiple subtypes, 12-25 targets


name: Gastrointestinal pathogen detection by multiplex amplified nucleic acid probe technique, multiple types, 12-25 targets


name: Detection test for gardnerella vaginalis (bacteria), direct probe technique


name: Gardnerella vaginalis detection by direct nucleic acid probe technique


name: Gardnerella vaginalis detection by amplified nucleic acid probe technique


name: Detection test for gardnerella vaginalis (bacteria), quantification


name: Gardnerella vaginalis quantification by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis B virus, amplified probe technique


name: Hepatitis B (HepB) virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis B virus, quantification


name: Hepatitis B (HepB) virus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis C virus, direct probe technique


name: Hepatitis C (HepC) virus detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis C virus, amplified probe technique


name: Hepatitis C (HepC) virus detection by amplified nucleic acid probe technique


name: Hepatitis C (HepC) virus detection by amplified nucleic acid probe technique with reverse transcription


name: Hepatitis C (HepC) virus quantification by nucleic acid probe technique


name: Hepatitis C (HepC) virus quantification by nucleic acid probe technique with reverse transcription


name: Hepatitis G virus detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis G virus, amplified probe technique


name: Hepatitis G virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Hepatitis G virus, quantification


name: Hepatitis G virus quantification by nucleic acid probe technique


name: Detection test by nucleic acid for herpes simplex virus, direct probe technique


name: Herpes simplex virus detection by direct nucleic acid probe technique


name: Herpes simplex virus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for herpes simplex virus, quantification


name: Herpes simplex virus quantification by nucleic acid probe technique


name: Herpes virus-6 detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for herpes virus-6, amplified probe technique


name: Herpes virus-6 detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for herpes virus-6, quantification


name: Herpes virus-6 quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for HIV-1 virus, amplified probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by amplified nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) detection by amplified nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for HIV-1 virus, quantification


name: Human immunodeficiency virus type 1 (HIV-1) quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 1 (HIV-1) quantification by nucleic acid probe technique with reverse transcription


name: Detection test by nucleic acid for HIV-2 virus, direct probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by direct nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by amplified nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) detection by amplified nucleic acid probe technique and reverse transcription


name: Detection test by nucleic acid for HIV-2 virus, quantification


name: Human immunodeficiency virus type 2 (HIV-2) quantification by nucleic acid probe technique


name: Human immunodeficiency virus type 2 (HIV-2) quantification by nucleic acid probe technique and reverse transcription


name: Detection test by nucleic acid for legionella pneumophila (water borne bacteria), direct probe technique


name: Legionella pneumophila detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique


name: Legionella pneumophila detection by amplified nucleic acid probe technique


name: Legionella pneumophila quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria species (bacteria), direct probe technique


name: Mycobacteria species detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria species (bacteria), amplified probe technique


name: Mycobacteria species detection by amplified nucleic acid probe technique


name: Mycobacteria species quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria tuberculosis (TB bacteria), direct probe technique


name: Mycobacteria tuberculosis detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria tuberculosis (TB bacteria), amplified probe technique


name: Mycobacteria tuberculosis detection by amplified nucleic acid probe technique


name: Mycobacteria tuberculosis quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria avium-intracellulare (bacteria), direct probe technique


name: Mycobacteria avium-intracellulare detection by direct nucleic acid probe technique


name: Mycobacteria avium-intracellulare detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Mycobacteria avium-intracellulare (bacteria), quantification


name: Mycobacteria avium-intracellulare quantification by nucleic acid probe technique


name: Detection test by nucleic acid for Mycoplasma pneumoniae (bacteria), direct probe technique


name: Mycoplasma pneumoniae detection by direct nucleic acid probe technique


name: Mycoplasma pneumoniae detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Mycoplasma pneumoniae (bacteria), quantification


name: Mycoplasma pneumoniae quantification by nucleic acid probe technique


name: Neisseria gonorrhoeae detection by direct nucleic acid probe technique


name: Detection test by nucleic acid for Neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique


name: Detection of Neisseria gonorrhoeae nucleic acid by amplified probe technique


name: Detection test by nucleic acid for Neisseria gonorrhoeae (gonorrhoeae bacteria), quantification


name: Neisseria gonorrhoeae quantification by nucleic acid probe technique


name: Detection test by nucleic acid for human papillomavirus (hpv), low-risk types


name: Human Papillomavirus (HPV) detection by nucleic acid for low-risk types


name: Detection test by nucleic acid for Human Papillomavirus (HPV), high-risk types


name: Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only


name: Human Papillomavirus (HPV) type 16 and 18 detection by nucleic acid probe technique


name: Human Papillomavirus (HPV) type 16, 18, and 45 detection by nucleic acid probe technique


name: Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets


name: Respiratory virus detection by nucleic acid using amplified probe technique, 3-5 targets


name: Respiratory virus detection by nucleic acid using multiplex reverse transcription technique, 3-5 targets


name: Respiratory virus detection by nucleic acid using amplified probe technique, 6-11 targets


name: Respiratory virus detection by nucleic acid using multiplex reverse transcription technique, 6-11 targets


name: Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 12-25 targets


name: Respiratory virus detection by nucleic acid using amplified probe technique, 12-25 targets


name: Respiratory virus detection by nucleic acid using multiplex reverse transcription technique, 12-25 targets


name: Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique


name: Respiratory syncytial virus detection by amplified nucleic acid probe technique


name: Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique


name: Amplifed DNA or RNA probe detection of severe acute respiratory syndrome coronavirus 2 (Covid-19) antigen


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid by amplified DNA probe technique


name: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid by amplified RNA probe technique


name: Detection test by nucleic acid for Staphylococcus aureus (bacteria), amplified probe technique


name: Staphylococcus aureus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Staphylococcus aureus, methicillin resistant (MRSA bacteria), amplified probe technique


name: Methicillin resistant Staphylococcus aureus (MRSA) detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Strep (Streptococcus, group A), amplified probe technique


name: Group A Streptococcus detection by amplified nucleic acid probe technique


name: Detection test by nucleic acid for Strep (Streptococcus, group A), quantification


name: Group A Streptococcus detection by nucleic acid using quantification


name: Detection test by nucleic acid for Strep (Streptococcus, group B), amplified probe technique


name: Group B Streptococcus detection by amplified nucleic acid probe technique


name: Trichomonas vaginalis detection by direct nucleic probe technique


name: Detection test by nucleic acid for Trichomonas vaginalis (genital parasite), amplified probe technique


name: Trichomonas vaginalis detection by amplified nucleic acid probe technique


name: Zika virus detection by amplified nucleic acid probe technique


name: Infectious agent detection by nucleic acid (not otherwise specified) using direct probe technique, each organism


name: Detection test by nucleic acid for organism, amplified probe technique


name: Infectious agent detection by nucleic acid (not other wise specified) using amplified probe technique, each organism


name: Detection test by nucleic acid for organism, quantification


name: Infectious agent (not otherwise specified) quantification by nucleic acid probe technique, each organism


name: Detection test by nucleic acid for multiple organisms, direct probe(s) technique


name: Infectious agent detection by nucleic acid using direct probe technique, multiple organisms


name: Infectious agent detection by nucleic acid using amplified probe technique, multiple organisms


name: Human immunodeficiency virus type 1 (HIV-1) antigen and HIV-1 and HIV-2 antibodies detection by immunoassay with direct optical observation


name: Human immunodeficiency virus type 1 (HIV-1) genotype analysis by nucleic acid of reverse transcriptase and protease regions


name: Analysis test by nucleic acid for Hepatitis C virus


name: Nucleic acid analysis of infectious agent genotype of hepatitis C (HepC) virus


name: Analysis test by nucleic acid for HIV-1 virus, other region


name: Human immunodeficiency virus type 1 (HIV-1) nucleic acid genotype analysis, other region


name: Analysis test by nucleic acid for cytomegalovirus, cytomegalovirus


name: Analysis test by nucleic acid for hepatitis b virus


name: Nucleic acid analysis of infectious agent genotype of hepatitis B (HepB) virus


name: Analysis test by nucleic acid for HIV-1 virus, first through 10 drugs tested


name: Human immunodeficiency virus type 1 (HIV-1) phenotype analysis by nucleic acid with drug resistance tissue culture analysis, first 1-10 drugs tested


name: Analysis test by nucleic acid for HIV-1 virus, each additional drug tested


name: Human immunodeficiency virus type 1 (HIV-1) phenotype analysis by nucleic acid with drug resistance tissue culture analysis, each additional drug tested


name: Analysis of non-viral infectious agent enzymatic activity


name: Gross necropsy with brain and spinal cord


name: Gross examination and necropsy with brain, for newborn


name: Gross examination and necropsy with brain, for stillborn


name: Gross and microscopic necropsy with brain and spinal cord


name: Gross and microscopic necropsy including brain, for infant


name: Gross and microscopic necropsy with brain, for newborn


name: Gross and microscopic necropsy with brain, for stillborn


name: Cytopathology on smear of fluid specimen (except cervical or vaginal) collected by brushing, with interpretation


name: Cytopathology on smear of fluid specimen (except cervical or vaginal) collected by washing, with interpretation


name: Cytopathology on smear of fluid specimen (except cervical or vaginal) collected by brushing using simple filter method, with interpretation


name: Cytopathology on smear of fluid specimen (except cervical or vaginal) collected by washing using simple filter method, with interpretation


name: Cell examination of specimen, concentration technique


name: Cytopathology by selective cellular enhancement technique and interpretation (excluding cervical or vaginal specimen)


name: Cytopathology on urinary tract specimen with manual morphometric analysis using in situ hybridization, 3-5 molecular probes


name: Cell examination of urine, computer-assisted


name: Cytopathology on urinary tract specimen with computer-assisted morphometric analysis using in situ hybridization, 3-5 molecular probes


name: Sex identification, peripheral blood smear


name: Cytopathology on cervical specimen with automated thin layer preparation and manual screening under physician supervision


name: Cytopathology on vaginal specimen with automated thin layer preparation and manual screening under physician supervision


name: Pap test, manual screening and rescreening


name: Cytopathology on cervical specimen with automated thin layer preparation, manual screening, and rescreening under physician supervision


name: Cytopathology on vaginal specimen with automated thin layer preparation, manual screening, and rescreening under physician supervision


name: Cytopathology on cervical smear with screening using automated system under physician supervision


name: Cytopathology on vaginal smear with screening using automated system under physician supervision


name: Pap test (Pap smear), automated system with manual rescreening


name: Cytopathology on cervical smear with screening using automated system and manual rescreening under physician supervision


name: Cytopathology on vaginal smear with screening using automated system and manual rescreening under physician supervision


name: Cytopathology on cervical smear with manual screening under physician supervision


name: Cytopathology on vaginal smear with manual screening under physician supervision


name: Pap test, slides, automated system with computer-assisted rescreening


name: Cytopathology on cervical smear with manual screening and computer-assisted rescreening under physician supervision


name: Cytopathology on vaginal smear with manual screening and computer-assisted rescreening under physician supervision


name: Pap test, slides, manual screening and rescreening


name: Cytopathology on cervical smear with manual screening and rescreening under physician supervision


name: Cytopathology on vaginal smear with manual screening and rescreening under physician supervision


name: Screening examination of specimen cells, preparation, screening and interpretation


name: Screening examination of specimen cells, extended study


name: Cytopathology smears any other source, extended study of 5 or more slides


name: Cytopathology smears any other source, extended study of 5 or more slides and multiple stains on smear


name: Cytopathology smears any other source, extended study of multiple stains on smear


name: Pap test, slides, manual screening (the Bethesda System)


name: Pap test, slides, manual screening and rescreening (the Bethesda System)


name: Cytopathology on cervical smear with manual screening and rescreening using Bethesda system under physician supervision


name: Cytopathology on vaginal smear with manual screening and rescreening using Bethesda system under physician supervision


name: Pap test, slides, manual screening and computer-assisted rescreening (the Bethesda System)


name: Cytopathology on cervical smear with manual screening and computer-assisted rescreening using Bethesda system under physician supervision


name: Cytopathology on vaginal smear with manual screening and computer-assisted rescreening using Bethesda system under physician supervision


name: Pap test, slides, manual screening and computer-assisted rescreening using cell selection (the Bethesda System)


name: Cytopathology on cervical smear with manual screening and computer-assisted rescreening using cell selection and review and using Bethesda system under physician supervision


name: Cytopathology on vaginal smear with manual screening and computer-assisted rescreening using cell selection and review and using Bethesda system under physician supervision


name: Pap test, automated thin layer preparation; automated system


name: Cytopathology on cervical specimen with automated thin layer preparation and screening using automated system under physician supervision


name: Cytopathology on vaginal specimen with automated thin layer preparation and screening using automated system under physician supervision


name: Pap test, automated thin layer preparation; automated system and manual rescreening


name: Cytopathology on cervical specimen with automated thin layer preparation and screening using automated system and manual rescreening under physician supervision


name: Cytopathology on vaginal specimen with automated thin layer preparation and screening using automated system and manual rescreening under physician supervision


name: Cytohistologic evaluation of fine needle aspirate to determine adequacy for diagnosis, first evaluation episode, each site


name: Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode


name: Cytohistologic evaluation of fine needle aspirate to determine adequacy for diagnosis, each separate additional evaluation episode, same site


name: Flow cytometry technique for DNA or cell analysis, first marker


name: Flow cytometry for detection of first cell surface marker


name: Flow cytometry for detection of first cytoplasmic marker


name: Flow cytometry for detection of first nuclear marker


name: Flow cytometry technique for DNA or cell analysis, each additional marker


name: Flow cytometry for detection of each additional cell surface marker


name: Flow cytometry for detection of each additional cytoplasmic marker


name: Flow cytometry for detection of each additional nuclear marker


name: Flow cytometry technique for DNA or cell analysis, 2 to 8 markers


name: Interpretation of flow cytometry, 2-8 markers


name: Flow cytometry technique for DNA or cell analysis, 9 to 15 markers


name: Interpretation of flow cytometry, 9-15 markers


name: Flow cytometry technique for DNA or cell analysis, 16 or more markers


name: Interpretation of flow cytometry, 16 or more markers


name: Tissue culture of lymphocytes for evaluation of non-neoplastic disorder


name: Tissue culture of skin biopsy for evaluation of non-neoplastic disorder


name: Tissue culture of tissue biopsy for evaluation of non-neoplastic disorder


name: Tissue culture of amniotic fluid cells for evaluation of non-neoplastic disorder


name: Tissue culture of chorionic villus cells for evaluation of non-neoplastic disorder


name: Chromosome analysis for genetic defects, baseline Sister Chromatid Exchange (SCE), 20-25 cells


name: Chromosome analysis for breakage syndrome using measurement of baseline Sister Chromatid Exchange (SCE), 20-25 cells


name: Chromosome analysis for genetic defects, baseline breakage, score 50-100 cells, count 20 cells


name: Chromosome analysis for breakage syndrome using measurement of baseline breakage, score 50-100 cells, count 20 cells, 2 karyotypes


name: Chromosome analysis for genetic defects, score 100 cells, clastogen stress


name: Chromosome analysis for genetic defects, count 5 cells


name: Chromosome analysis for genetic defects, count 15-20 cells


name: Chromosome analysis for genetic defects, count 45 cells for mosaicism


name: Chromosome analysis for mosaicism, count 45 cells from 2 karyotypes with banding


name: Chromosome analysis for genetic defects, analyze 20-25 cells


name: Chromosome analysis of amniotic fluid, count 15 cells from single karyotype with banding


name: Chromosome analysis of chorionic villus, count 15 cells from single karyotype with banding


name: Chromosome analysis, in situ for amniotic fluid cells, count cells from 6-12 colonies, single karyotype, with banding


name: Molecular cytogenetics using DNA probe, each probe


name: Molecular cytogenetics using chromosomal in situ hybridization, 3-5 cells


name: Chromosome analysis for genetic defects, analyze 10-30 cells


name: Molecular cytogenetics using chromosomal in situ hybridization, 10-30 cells


name: Chromosome analysis for genetic defects, analyze 25-99 cells


name: Molecular cytogenetics using interphase in situ hybridization, 25-99 cells


name: Chromosome analysis for genetic defects, analyze 100-300 cells


name: Molecular cytogenetics using interphase in situ hybridization, 100-300 cells


name: Chromosome analysis for genetic defects, additional specialized banding technique


name: Chromosome analysis for genetic defects, additional cells counted, each study


name: Chromosome analysis for genetic defects, additional high resolution study


name: Surgical pathology with gross and microscopic examination of foreskin of newborn


name: Surgical pathology with gross and microscopic examination of foreskin (other than newborn)


name: Surgical pathology with gross and microscopic examination of specimen from biopsy of oropharynx


name: Surgical pathology with gross and microscopic examination of specimen from biopsy of urethra


name: Surgical pathology with gross and microscopic examination of specimen from resection of brain (other than for tumor)


name: Surgical pathology with gross and microscopic examination of specimen from resection of meninges (other than for tumor)


name: Surgical pathology with gross and microscopic examination of specimen from resection of ovary (non-neoplastic)


name: Surgical pathology with gross and microscopic examination of specimen from resection of ovary with fallopian tube (non-neoplastic)


name: Surgical pathology with gross and microscopic examination of specimen from skin (other than cyst, tag, debridement, and plastic repair)


name: Surgical pathology with gross and microscopic examination of specimen from soft tissue (other than tumor, mass, lipoma, and debridement)


name: Surgical pathology with gross and microscopic examination of specimen from testis (other than tumor, biopsy, and castration)


name: Surgical pathology with gross and microscopic examination of specimen from transbronchial biopsy of lung


name: Surgical pathology with gross and microscopic examination of specimen from uterine myomectomy for leiomyoma (without uterus)


name: Surgical pathology with gross and microscopic examination of specimen from extensive resection of soft tissue for neoplasm


name: Surgical pathology with gross and microscopic examination of specimen from partial resection of larynx with regional lymph nodes


name: Surgical pathology with gross and microscopic examination of specimen from subtotal resection of bladder


name: Surgical pathology with gross and microscopic examination of specimen from subtotal resection of vulva


name: Surgical pathology consultation and report on referred material requiring preparation of slides


name: Pathology examination of specimen during surgery, first tissue block


name: Intraoperative pathology examination with frozen section, single specimen


name: Pathology examination of specimen during surgery, each additional tissue block


name: Intraoperative pathology examination with frozen section, each additional specimen


name: Pathology cytologic examination of specimen during surgery, initial site


name: Intraoperative cytologic examination, initial site


name: Pathology cytologic examination of specimen during surgery, each additional site


name: Intraoperative cytologic examination, each additional site


name: Special stained specimen slides to examine tissue, each additional procedure


name: Immunocytochemistry per specimen for each additional single antibody stain procedure


name: Immunohistochemistry per specimen for each additional single antibody stain procedure


name: Special stained specimen slides to examine tissue, initial procedure


name: Immunocytochemistry per specimen for initial single antibody stain procedure


name: Immunohistochemistry per specimen for initial single antibody stain procedure


name: Immunocytochemistry per specimen for each multiplex antibody stain procedure


name: Immunohistochemistry per specimen for each multiplex antibody stain procedure


name: Antibody evaluation, initial single antibody stain procedure


name: Immunofluorescent study of antibody using direct method, per specimen of initial single antibody stain procedure


name: Antibody evaluation, each additional single antibody stain procedure


name: Antibody identification using immunofluorescence, each additional single antibody stain procedure


name: Microscopic genetic analysis of tumor, manual


name: Manual quantitative morphometric analysis of tumor immunohistochemistry, per specimen of each single antibody stain procedure


name: Manual semiquantitative morphometric analysis of tumor immunohistochemistry, per specimen of each single antibody stain procedure


name: Microscopic genetic analysis of tumor, using computer-assisted technology


name: Quantitative morphometric analysis of tumor immunohistochemistry using computer-assisted technology, per specimen of each single antibody stain procedure


name: Semiquantitative morphometric analysis of tumor immunohistochemistry using computer-assisted technology, per specimen of each single antibody stain procedure


name: Examination of archival tissue for genetic analysis


name: Genetic sequencing localization, each additional procedure


name: In situ hybridization, each additional single probe strain


name: Genetic sequencing localization, initial procedure


name: In situ hybridization, initial single probe stain


name: Genetic sequencing localization, each multiplex procedure


name: In situ hybridization, each multiplex probe stain


name: Quantitative morphometric analysis with in situ hybridization using computer-assisted technology, initial single probe strain


name: Semiquantitative morphometric analysis with in situ hybridization using computer-assisted technology, initial single probe strain


name: Quantitative morphometric analysis with in situ hybridization using computer-assisted technology, each additional single probe strain


name: Semiquantitative morphometric analysis with in situ hybridization using computer-assisted technology, each additional single probe strain


name: Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure


name: Quantitative morphometric analysis with in situ hybridization using computer-assisted technology, each multiplex probe strain


name: Semiquantitative morphometric analysis with in situ hybridization using computer-assisted technology, each multiplex probe strain


name: Microscopic genetic analysis of tissue, manual, initial procedure


name: Manual quantitative morphometric analysis with in situ hybridization, per specimen of initial single probe stain procedure


name: Manual semiquantitative morphometric analysis with in situ hybridization, per specimen of initial single probe stain procedure


name: Quantitative morphometric analysis with in situ hybridization, each additional single probe strain


name: Semiquantitative morphometric analysis with in situ hybridization, each additional single probe strain


name: Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure


name: Protein analysis of tissue by Western Blot with interpretation and report, each immunological probe for band identification


name: Real time optical endomicroscopic image interpretation and report, each endoscopic session


name: Referred optical endomicroscopic image interpretation and report, each endoscopic session


name: Quantitative transcutaneous measurement of hemoglobin (Hgb)


name: Quantitative transcutaneous measurement of carboxyhemoglobin, per day


name: Hemoglobin measurement, per day, methemoglobin


name: Quantitative transcutaneous measurement of methemoglobin, per day


name: Caffeine halothane contracture test (CHCT) for malignant hyperthermia susceptibility with interpretation and report


name: Cell count and differential count on body fluid (except blood)


name: Crystal identification in body fluid (except urine) using light microscopy with polarizing lens analysis


name: Culture of embryo with embryo coculture, less than 4 days


name: Culture of oocyte with oocyte coculture, less than 4 days


name: Sperm identification from testicular aspirate (other than seminal fluid)


name: Simple preparation of sperm isolation with semen analysis for diagnosis


name: Simple preparation of sperm isolation with semen analysis for insemination


name: Complex preparation of sperm isolation with semen analysis for diagnosis


name: Complex preparation of sperm isolation with semen analysis for insemination


name: Assisted oocytes fertilization using microtechnique, 10 or fewer


name: Assisted oocyte fertilization (fertility procedure), greater than 10 oocytes


name: Assisted oocytes fertilization using microtechnique, 11 or more


name: Biopsy of embryo blastomere using microtechnique, 5 or fewer


name: Biopsy of oocyte polar body using microtechnique, 5 or fewer


name: Biopsy of embryo blastomere using microtechnique, 6 or more


name: Biopsy of oocyte polar body using microtechnique, 6 or more


name: Semen analysis with evaluation of sperm motility including Huhner test


name: Semen analysis with evaluation of sperm presence including Huhner test


name: Thawing of each aliquot of cryopreserved semen


name: Thawing of each aliquot of cryopreserved sperm


name: Thawing of each aliquot of cryopreserved oocytes


name: Human erythrocyte gene analysis of 35 antigens from 11 blood groups in whole blood, common red blood cell (RBC) alleles reported


name: Measurement of ascorbic acid, succinic acid, and carnitine in urine by liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring acquisition, algorithm reported as likelihood of adenomatous polyps for colorectal oncology


name: ERG, PCA3, and SPDEF gene expression profile using real time reverse transcription polymerase chain reaction (RT-PCR) in urine specimen, algorithm reported as risk score for prostate cancer


name: Next-generation sequencing of DNA, 16S, and 23S rRNA, gyrA, pbp1, rdxA, and rpoB for detection of Helicobacter pylori and antibiotic resistance in fecal sample reported as positive or negative, to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin reported as positive or negative, to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin


name: Next-generation sequencing of DNA, 16S, and 23S rRNA, gyrA, pbp1, rdxA, and rpoB for detection of Helicobacter pylori and antibiotic resistance in fresh tissue reported as positive or negative, to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin


name: Next-generation sequencing of DNA, 16S, and 23S rRNA, gyrA, pbp1, rdxA, and rpoB for detection of Helicobacter pylori and for prediction of antibiotic resistance in formalin-fixed paraffin-embedded tissue sample, reported as positive or negative for resistance to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin


name: Gene analysis for detection of ERBB2 (HER2) copy number variations associated with breast cancer using FISH in tumor cells from formalin-fixed paraffin-embedded tissue isolated by image-based dielectrophoresis (DEP) sorting, reported as ERBB2 gene amplified or nonamplified


name: Typing of bacterial strain by whole genome sequencing with phylogenetic-based report of strain relatedness, per submitted isolate


name: Prescription drug monitoring for presence of drug in oral fluid specimen using liquid chromatography-tandem mass spectrometry (LC-MS/MS)


name: DNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow


name: RNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow


name: RNA analysis for detection of BCR/ABL1 major and minor breakpoint fusion transcripts associated with hematolymphoid cancer using quantitative polymerase chain reaction (PCR) amplification in blood specimen, with report of fusion not detected or detected with quantitation


name: RNA analysis for detection of BCR/ABL1 major and minor breakpoint fusion transcripts associated with hematolymphoid cancer using quantitative polymerase chain reaction (PCR) amplification in bone marrow specimen, with report of fusion not detected or detected with quantitation


name: JAK2 mutation test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow


name: DNA analysis for detection of JAK2 mutation associated with hematolymphoid cancer by polymerase chain reaction (PCR) amplification of exons 12-14 and sequence analysis in blood specimen, with report


name: DNA analysis for detection of JAK2 mutation associated with hematolymphoid cancer by polymerase chain reaction (PCR) amplification of exons 12-14 and sequence analysis in bone marrow specimen, with report


name: Thyroid cancer microRNA profiling by reverse transcription polymerase chain reaction (RT-PCR) of 10 microRNA sequences in fine needle aspirate, algorithm reported as a positive or negative result for moderate to high risk of malignancy


name: DNA genotyping of internal tandem duplication, p.D835, p.I836 in mononuclear cells for assessment of acute myelogenous leukemia, reported as detection or nondetection of FLT3 mutation and indication for or against the use of midostaurin


name: Quantitative measurement of glycosylated acute phase proteins (GlycA) using nuclear magnetic resonance spectroscopy


name: Quantitative measurement of tenofovir in urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS)


name: DNA and mRNA next-generation sequencing of 112 genes with interrogation for sequence variants and rearrangements in fine needle aspirate of thyroid nodule for assessment of thyroid cancer, algorithmic analysis reported as a categorical result


name: Janus kinase 2 (JAK2) gene analysis, targeted sequence analysis, exons 12-15


name: Drug metabolism, targeted gene sequence analysis (CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLCO1B1, VKORC1, and rs12777823)


name: Warfarin drug response, targeted sequence analysis (CYP2C9, CYP4F2, VKORC1, and rs12777823)


name: Quantitative measurement of Vitamin D, 25 hydroxy D2, and D3 in serum microsample using liquid chromatography-tandem mass spectrometry (LC-MS/MS)


name: Quantitative major breakpoint translocation analysis of BCR/ABL1 (t(9;22))


name: IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group (IgM)


name: Detection of tick-borne relapsing fever (TBRF) Borrelia group IgM antibody to 4 recombinant protein groups using immunoblot


name: Detection of tick-borne relapsing fever (TBRF) Borrelia group IgG antibody to 4 recombinant protein groups using immunoblot


name: Breast ductal carcinoma in situ, mRNA gene expression profiling using real time reverse transcription polymerase chain reaction (RT-PCR) of 12 genes (7 content and 5 housekeeping) in formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score


name: Fms-related tyrosine kinase 3 (FLT3) quantitative gene analysis for internal tandem duplication (ITD) variants


name: Prostate cancer mRNA gene expression profiling using real time reverse transcription polymerase chain reaction (RT-PCR) of 17 genes (12 content and 5 housekeeping) in formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score


name: Solid organ neoplasia-targeted DNA sequencing of protein-coding exons of 468 cancer-associated genes with interrogation for somatic mutations and microsatellite instability, matched with normal specimens, in formalin-fixed paraffin-embedded tumor tissue, report of clinically significant mutation


name: High resolution fractionation and quantitation of all 5 major lipoprotein classes and subclasses of high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) in blood using vertical auto profile ultracentrifugation


name: Assay of cell-free DNA, polymerase chain reaction (PCR) of 96 DNA target sequences (94 single nucleotide polymorphism targets and 2 control targets) in plasma for assessment of heart transplant rejection


name: Quantitative detection of antibodies to Merkel cell polyoma virus oncoprotein in serum


name: Detection of antibodies to Merkel cell polyoma virus capsid protein (VP1) in serum


name: Genomic targeted sequence analysis of chromosome 2, using circulating cell-free fetal DNA in maternal blood for detection of twin zygosity


name: Transcutaneous measurement of tissue oxygenation, oxyhemoglobin, deoxyhemoglobin, and papillary and reticular dermal hemoglobin concentrations using spatial frequency domain imaging and multispectral analysis


name: Measurement of 32 amines associated with autism spectrum disorder in serum by liquid chromatography-tandem mass spectrometry (LC-MS/MS), algorithm reported as metabolic signature associated with autism spectrum disorder


name: Detection of Treponema pallidum antibody by qualitative immunoassay using rapid plasma reagin (RPR)


name: Syphilis test by detection of non-treponemal antibody by qualitative immunoassay using rapid plasma reagin (RPR)


name: Colorectal cancer microRNA reverse transcription polymerase chain reaction (RT-PCR) gene expression profiling of miR-31-3p in formalin-fixed paraffin-embedded tissue, algorithm reported as an expression score


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) targeted gene sequence analysis of CYP2D7-2D7 hybrid gene


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) targeted gene sequence analysis of CYP2D7-2D6 hybrid gene


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) targeted gene sequence analysis of non-duplicated gene when duplication/multiplication is trans in targeted sequence


name: Cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) 5' gene duplication/multiplication analysis of targeted sequence


name: Mass spectrometric analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130 in plasma, with 5 clinical risk factors (age, smoking status, nodule diameter, nodule-spiculation status and nodule location), algorithm reported as a categorical probability of lung malignancy


name: Definitive drug testing for 90 or more drugs by definitive chromatography with mass spectrometry and presumptive drug testing for any number of drug classes, by instrument chemistry analyzer using immunoassay, in urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions, per date of service


name: Definitive drug testing for 90 or more substances by definitive chromatography with mass spectrometry and presumptive drug testing for any number of drug classes, by instrument chemistry analyzer using immunoassay, in urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions, per date of service


name: Melanoma mRNA gene expression profiling by reverse transcriptase quantitative polymerase chain reaction (RTqPCR) for PRAME and LINC00518 on superficial specimen collected using adhesive patch


name: Screening for colorectal cancer or adenoma by cell enumeration of circulating tumor cells in whole blood, algorithm reported as positive or negative


name: Prescription drug monitoring of 65 common drugs in urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS), each drug reported detected or not detected


name: Hereditary colon cancer disorders genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (15 genes sequencing for detection of deletion and duplication], EPCAM and GREM1 detection for deletion and duplication only)


name: Hereditary breast cancer-related disorders genomic sequence analysis panel utilizing a combination of next-generation sequencing (NGS), Sanger, multiplex ligation-dependent probe amplification (MLPA), and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes sequencing for detection of deletion and duplication)


name: Hereditary ovarian cancer genomic sequence analysis panel utilizing a combination of next-generation sequencing (NGS), Sanger, multiplex ligation-dependent probe amplification (MLPA), and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes sequencing for detection of deletion and duplication, epithelial cell adhesion molecule (EPCAM) deletion and duplication only)


name: Multiplex electrochemiluminescent immunoassay of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) in isolated fresh plasma, combined with longitudinal clinical data, algorithm reported as probability score for rapid kidney function decline (RKFD)


name: Multiplex electrochemiluminescent immunoassay of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) in isolated fresh plasma, combined with longitudinal clinical data, including APOL1 genotype, algorithm reported as probability score for rapid kidney function decline (RKFD)


name: Multiplex electrochemiluminescent immunoassay of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) in isolated frozen plasma, combined with longitudinal clinical data, algorithm reported as probability score for rapid kidney function decline (RKFD)


name: Multiplex electrochemiluminescent immunoassay of tumor necrosis factor receptor 1A, receptor superfamily 2 (TNFR1, TNFR2), and kidney injury molecule-1 (KIM-1) in isolated frozen plasma, combined with longitudinal clinical data, including APOL1 genotype, algorithm reported as probability score for rapid kidney function decline (RKFD)


name: Evaluation of gastric emptying by serial collection of 7 timed breath specimens after administration non-radioisotope carbon-13 (13C) spirulina substrate and analysis by gas isotope ratio mass spectrometry, reported as rate of 13 carbon dioxide (CO2) excretion


name: Detection of Clostridium difficile toxin antigen in stool by qualitative multiple-step method immunoassay


name: Whole slide digital imaging of esophageal cells in formalin-fixed paraffin-embedded tissue, including morphometric analysis, computer-assisted quantitative immunolabeling of 9 protein biomarkers (p16, AMACR, p53, CD68, COX-2, CD45RO, HIF1a, HER-2, K20) and morphology, algorithm reported as risk of progression to high-grade dysplasia or cancer


name: Real-time polymerase chain reaction (PCR) for detection of DNA from 4 Aspergillus species (Aspergillus fumigatus, Aspergillus terreus, Aspergillus niger, and Aspergillus flavus) in blood, qualitative reporting of presence or absence of each species


name: Real-time polymerase chain reaction (PCR) for detection of DNA from 4 Aspergillus species (Aspergillus fumigatus, Aspergillus terreus, Aspergillus niger, and Aspergillus flavus) in lavage fluid, qualitative reporting of presence or absence of each species


name: Real-time polymerase chain reaction (PCR) for detection of DNA from 4 Aspergillus species (Aspergillus fumigatus, Aspergillus terreus, Aspergillus niger, and Aspergillus flavus) in tissue, qualitative reporting of presence or absence of each species


name: Measurement of multiple oral oncology drugs by definitive tandem mass spectrometry with chromatography, in plasma from capillary blood, quantitative report with steady-state range for prescribed drug when detected